(PDF) 870 Palivizumab Prophylaxis for VRS Infection in

870 Palivizumab Prophylaxis for VRS Infection in Preterm Infants With Gestational Age ≤30 Weeks: Compliance, Efficacy and Adverse Events

Pediatric Research - United States

doi 10.1203/00006450-201011001-00870

Full Text

Abstract

Available in full text

Categories

Date

November 1, 2010

Authors

Publisher

Springer Science and Business Media LLC

Related search

Gentamicin Pharmacokinetics in Preterm Infants ≤ 28 Weeks Gestational Age

Pediatric Research

English

Safety of Routine Magnetic Resonance Imaging in Critically Ill Preterm Infants at 30 Weeks Gestational Age

Pediatric Research

English

Morbidity and Mortality of Preterm Infants Less Than 26 Weeks of Gestational Age

Minerva Pediatrica

English

Postnatal Brain Growth Assessed by Sequential Cranial Ultrasonography in Infants Born <30 Weeks' Gestational Age

American Journal of Neuroradiology

Nuclear Medicine

English

135 Early Ibuprofen Intervention for Preterm Infants Under 28 Gestational Weeks

Pediatric Research

English

Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis

Archives of Disease in Childhood: Fetal and Neonatal Edition

English

Thyroxine Administration to Infants of Less Than 30 Weeks' Gestational Age Does Not Increase Plasma Triiodothyronine Concentrations

European Journal of Endocrinology

English

OP10.06: Prediction of Preterm Birth and Small-For-Gestational-Age Neonates by Fetal Biometry at 19-24 Gestational Weeks

Ultrasound in Obstetrics and Gynecology

Nuclear Medicine

Ultrasound Technology

Reproductive Medicine

English

Randomised Controlled Trial of Postnatal Sodium Supplementation in Infants of 25-30 Weeks Gestational Age: Effects on Cardiopulmonary Adaptation

Archives of Disease in Childhood: Fetal and Neonatal Edition

English